-
1
المؤلفون: Yuanxin Rong
المصدر: Journal of Commercial Biotechnology. 26
مصطلحات موضوعية: Economics and Econometrics, Value creation, Process management, Stage (stratigraphy), Management of Technology and Innovation, Perspective (graphical), Business, Architectural technology, Biotechnology
-
2
المؤلفون: Hesham Mohamed, Teresa Zyczynski, Yuanxin Rong, Elisabetta Abruzzese, Loretta A. Williams, Susanne Saussele, Dong-Wook Kim, Javier Pinilla-Ibarz
المصدر: Annals of Hematology
مصطلحات موضوعية: Adult, Male, Quality of life, medicine.medical_specialty, Dasatinib, Young Adult, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Humans, Medicine, Patient Reported Outcome Measures, Adverse effect, Protein Kinase Inhibitors, Tyrosine kinase, Aged, Aged, 80 and over, Hematology, Drug Substitution, Adverse effects, business.industry, Chronic myeloid leukemia, Myeloid leukemia, Imatinib, General Medicine, Middle Aged, Rash, Treatment Outcome, Imatinib mesylate, Tolerability, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Imatinib Mesylate, Female, Original Article, medicine.symptom, business, 030215 immunology, medicine.drug
-
3
المؤلفون: Andrew J. Buckler, Binsheng Zhao, Andrea Perrone, Matthias Thorn, Rene Korn, P. David Mozley, Claus Bendtsen, Yuanxin Rong, Lawrence H. Schwartz, Luduan Zhang
المصدر: Translational Oncology. 5:19-25
مصطلحات موضوعية: Cancer Research, Pathology, medicine.medical_specialty, Reproducibility, Potential impact, business.industry, Disease progression, medicine.disease, Patient management, Clinical trial, Oncology, medicine, In patient, Analysis tools, Lung cancer, business, Nuclear medicine
-
4
المؤلفون: Yuanxin Rong, Cong Li, Shining Wang, John Nemunaitis, Ulka N. Vaishampayan, Yaping Shou, Dejan Juric, Anthony J. Olszanski
المصدر: Journal of Clinical Oncology. 36:e15124-e15124
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, business.industry, Dual inhibitor, Syk, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Cancer research, Medicine, In patient, Nivolumab, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ea0fc4022cb59d6d9a9b025b4ac798fe
https://doi.org/10.1200/jco.2018.36.15_suppl.e15124 -
5
المؤلفون: Yuanxin Rong, Ling Wang, Yaping Shou, Dejan Juric, Kate Stumpo, Karuppiah Kannan, John Nemunaitis, Huifeng Niu, Stephanie Faucette
المصدر: Journal of Clinical Oncology. 35:TPS3104-TPS3104
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, 010405 organic chemistry, business.industry, Dual inhibitor, Syk, Pharmacology, 01 natural sciences, 0104 chemical sciences, 010404 medicinal & biomolecular chemistry, Internal medicine, medicine, In patient, Nivolumab, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::18b8a161568cc78710d8e58feac20443
https://doi.org/10.1200/jco.2017.35.15_suppl.tps3104 -
6
المؤلفون: Yuanxin Rong
المصدر: Pharmaceutical Regulatory Affairs: Open Access.
مصطلحات موضوعية: Clinical trial, Flexibility (engineering), Drug development, Scope (project management), Risk analysis (engineering), Operations research, Order (exchange), business.industry, Adaptive design, Exploratory research, Medicine, business, Regulatory affairs
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b6e818e6f7a3161610146352faccbf88
https://doi.org/10.4172/2167-7689.1000116 -
7
المؤلفون: Aimee Foreman, Carlo Gambacorti, Mauricette Michallet, Stuart L. Goldberg, Rüdiger Hehlmann, Ron Paquette, Bengt Simonsson, Yuanxin Rong, Jorge E. Cortes, Michael J. Mauro, Teresa Zyczynski, Aleksandra Zagorska, Brian Calimlim
المصدر: Blood. 128:937-937
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Cell Biology, Hematology, Odds ratio, Biochemistry, Discontinuation, Dasatinib, 03 medical and health sciences, 0302 clinical medicine, Clinical research, Intolerances, Nilotinib, Interquartile range, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, business, 030215 immunology, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6e7b6e69b9408eb359d5bc9f3ca61a04
https://doi.org/10.1182/blood.v128.22.937.937